Dr Liz Roper
Dr Liz Roper is Partner at Epidarex Capital Capital and currently serves on the board of Edinburgh Molecular Imaging, Caldan Therapeutics, Enterprise Therapeutics and Nodthera. She has more than 15 years experience in the Life Science and Healthcare industry. Prior to joining Epidarex, Dr Roper was the Head of Business Development at Chroma Therapeutics, an Oxford-based venture-backed drug discovery and development company focused on inflammatory disorders and oncology. She is a former executive with the Life Science venture capital team at the Investments Division of The Wellcome Trust and also a former member of the Life Science team at Atlas Ventures, London. Dr Roper holds a BSc in Biochemistry (1st class) from the University College Cork, and a PhD from the Imperial Cancer Research Fund.